Source link : https://newshealth.biz/health-news/pcsk9-inhibitor-after-heart-transplant-turns-in-mixed-results/
(MedPage Today) — NEW ORLEANS — Treatment with the PCSK9 inhibitor alirocumab (Praluent) safely lowered LDL cholesterol versus placebo in transplant patients already on rosuvastatin, but did not reduce the development of cardiac allograft vasculopathy… Source link : https://www.medpagetoday.com/meetingcoverage/aha/118534 Author : Publish date : 2025-11-14 19:55:00 Copyright for syndicated content belongs to the linked Source.
The post PCSK9 Inhibitor After Heart Transplant Turns in Mixed Results first appeared on News Health.
—-
Author : News Health
Publish date : 2025-11-14 19:55:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8